triiodothyronine has been researched along with fibrin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffman, M; Lenkowski, A; Lockhart, E; Sauls, DL; Warren, ME; Wilhelm, SE | 1 |
| Genoud, V; Kordich, LC; Lauricella, AM; Quintana, I | 1 |
| Jakubowski, H; Perła-Kaján, J; Sikora, M; Skrzydlewski, P | 1 |
| Kooistra, T; Koolwijk, P; Lansink, M; van Hinsbergh, V | 1 |
| Barber, KJ; Bulmer, JN; Franklyn, JA; Khanim, FL; Kilby, MD; McCabe, CJ; Whitley, GS | 1 |
| Altun, BU; Arikan, E; Demir, M; Guldiken, S; Kara, M; Turgut, B | 1 |
1 trial(s) available for triiodothyronine and fibrin
| Article | Year |
|---|---|
Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure/function in coronary artery disease.
Topics: Coronary Artery Disease; Fibrin; Folic Acid; Homocysteine; Humans; Myocardial Infarction; Prognosis; Risk Factors; Thrombosis; Vitamin B 12; Vitamin B Complex | 2022 |
5 other study(ies) available for triiodothyronine and fibrin
| Article | Year |
|---|---|
Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
Topics: Amino Acid Sequence; Blood Coagulation; Dose-Response Relationship, Drug; Fibrin; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Lysine; Models, Biological; Molecular Sequence Data; Plasminogen; Protein Binding; Radiation-Protective Agents; Structure-Activity Relationship; Thrombosis; Tissue Plasminogen Activator | 2006 |
Impact of homocysteine-thiolactone on plasma fibrin networks.
Topics: Animals; Blood Coagulation; Cattle; Fibrin; Homocysteine; Humans; Plasma | 2014 |
Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression.
Topics: Aprotinin; Calcitriol; Capillaries; Cell Culture Techniques; Cells, Cultured; Drug Interactions; Endothelium, Vascular; Extracellular Matrix; Fibrin; Fibrinolysin; Fibroblast Growth Factor 2; Gene Expression Regulation; Gonadal Steroid Hormones; Humans; Male; Morphogenesis; Neovascularization, Physiologic; Polymerase Chain Reaction; Receptors, Cell Surface; Receptors, Retinoic Acid; Receptors, Steroid; Receptors, Urokinase Plasminogen Activator; Retinoids; RNA, Messenger; Steroids; Tissue Plasminogen Activator; Triiodothyronine; Tumor Necrosis Factor-alpha; Urokinase-Type Plasminogen Activator | 1998 |
The in vitro effects of triiodothyronine on epidermal growth factor-induced trophoblast function.
Topics: Cell Division; Cell Line, Transformed; Cell Movement; Choriocarcinoma; Epidermal Growth Factor; Female; Fibrin; Gels; Humans; In Vitro Techniques; Neoplasm Invasiveness; Pregnancy; Thyroid Hormone Receptors alpha; Thyroid Hormone Receptors beta; Triiodothyronine; Trophoblasts; Uterine Neoplasms | 2005 |
Global fibrinolytic capacity in patients with subclinical hypothyroidism.
Topics: Adult; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Hypothyroidism; Statistics, Nonparametric; Thyrotropin; Thyroxine; Tissue Plasminogen Activator; Triiodothyronine | 2005 |